Content development of the VISION-Cog: a novel tool to assess cognitive impairment in visually impaired older adults in Singapore.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
10 10 2023
Historique:
medline: 1 11 2023
pubmed: 11 10 2023
entrez: 10 10 2023
Statut: epublish

Résumé

Current cognitive screening and diagnostic instruments rely on visually dependent tasks and are, therefore, not suitable to assess cognitive impairment (CI) in visually impaired older adults. We describe the content development of the VISually Independent test battery Of NeuroCOGnition (VISION-Cog)-a new diagnostic tool to evaluate CI in visually impaired older Singaporean adults. The content development phase consisted of two iterative stages: a neuropsychological consultation and literature review (stage 1) and an expert-panel discussion (stage 2). In stage 1, we investigated currently available neuropsychological test batteries for CI to inform constructions of our preliminary test battery. We then deliberated this battery during a consensus meeting using the Modified Nominal Group technique (stage 2) to decide, via agreement of five experts, the content of a pilot neuropsychological battery for the visually impaired. Singapore Eye Research Institute. Stakeholders included researchers, psychologists, neurologists, neuro-ophthalmologists, geriatricians and psychiatrists. pilot VISION-Cog. The two-stage process resulted in a pilot VISION-Cog consisting of nine vision-independent neuropsychological tests, including the modified spatial memory test, list learning, list recall and list recognition, adapted token test, semantic fluency, modified spatial analysis, verbal subtests of the frontal battery assessment, digit symbol, digit span forwards, and digit span backwards. These tests encompassed five cognitive domains-memory and learning, language, executive function, complex attention, and perceptual-motor abilities. The expert panel suggested improvements to the clarity of test instructions and culturally relevant test content. These suggestions were incorporated and iteratively pilot-tested by the study team until no further issues emerged. We have developed a five-domain and nine-test VISION-Cog pilot instrument capable of replacing vision-dependent diagnostic batteries in aiding the clinician-based diagnosis of CI in visually impaired older adults. Subsequent phases will examine the VISION-Cog's feasibility, comprehensibility and acceptability; and evaluate its diagnostic performance.

Identifiants

pubmed: 37816566
pii: bmjopen-2022-070850
doi: 10.1136/bmjopen-2022-070850
pmc: PMC10565319
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e070850

Informations de copyright

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Front Aging Neurosci. 2022 Apr 13;14:838194
pubmed: 35493928
Ophthalmology. 2021 Jul;128(7):981-992
pubmed: 33333104
Age Ageing. 2022 May 1;51(5):
pubmed: 35639799
J Clin Exp Neuropsychol. 1998 Jun;20(3):310-9
pubmed: 9845158
BMC Fam Pract. 2018 Jul 18;19(1):117
pubmed: 30021508
Int Psychogeriatr. 2017 Nov;29(11):1771-1784
pubmed: 28691649
Aging Dis. 2020 Dec 1;11(6):1444-1458
pubmed: 33269099
Optom Vis Sci. 2010 Dec;87(12):1037-43
pubmed: 21037492
Int J Clin Pharm. 2016 Jun;38(3):655-62
pubmed: 26846316
J Clin Exp Neuropsychol. 1994 Apr;16(2):223-31
pubmed: 8021309
J Palliat Med. 2021 Dec;24(12):1867-1871
pubmed: 34726929
J Clin Exp Neuropsychol. 2007 Jul;29(5):467-76
pubmed: 17564912
Behav Res Methods. 2009 Nov;41(4):1190-200
pubmed: 19897828
Alzheimer Dis Assoc Disord. 2014 Apr-Jun;28(2):106-12
pubmed: 24322485
Clin Neuropsychol. 2020 Jan;34(1):140-157
pubmed: 30983493
Age Ageing. 2013 Jan;42(1):98-102
pubmed: 23108164
JAMA. 2020 Feb 25;323(8):764-785
pubmed: 32096857
J Neurol Sci. 2002 Nov 15;203-204:49-52
pubmed: 12417356
Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2015;22(4):413-37
pubmed: 25325767
Arch Clin Neuropsychol. 2014 Aug;29(5):442-55
pubmed: 24903208
Asia Pac J Public Health. 2014 May;26(3):310-9
pubmed: 22535554
Clin Neuropsychol. 2010;24(5):811-26
pubmed: 20560092
Neurol Clin Pract. 2019 Apr;9(2):109-117
pubmed: 31041124

Auteurs

Tai Anh Vu (TA)

Health Services and Systems Research, Duke-NUS Medical School, Singapore.

Eva Fenwick (E)

Health Services and Systems Research, Duke-NUS Medical School, Singapore.
Population Health Research, Singapore Eye Research Institute, Singapore.

Kinjal Doshi (K)

Department of Psychology, National University of Singapore, Singapore.

Preeti Gupta (P)

Health Services and Systems Research, Duke-NUS Medical School, Singapore.
Population Health Research, Singapore Eye Research Institute, Singapore.

Shin Yi Quek (SY)

Department of Psychology, Ng Teng Fong General Hospital, Singapore.

Christopher Chen (C)

Deaprtment of Pharmacology and Psychological Medicine, National University of Singapore, Singapore.

Simon Ting (S)

Department of Neurology, National Neuroscience Institute, Tan Tock Seng Hospital, Singapore.

Adeline S L Ng (ASL)

Department of Neurology, National Neuroscience Institute, Tan Tock Seng Hospital, Singapore.

Philip Yap (P)

Department of Geriatric Medicine, Khoo Teck Puat Hospital, Singapore.

Donald Yeo (D)

KALL Psychological & Counselling Services Pte Ltd, Singapore.

Dan Milea (D)

Health Services and Systems Research, Duke-NUS Medical School, Singapore.
Population Health Research, Singapore Eye Research Institute, Singapore.
Rothschild Foundation Hospital, Paris, France.

Ecosse Luc Lamoureux (EL)

Health Services and Systems Research, Duke-NUS Medical School, Singapore ecosse@unimelb.edu.au.
Department of Ophthalmology, The University of Melbourne, Melbourne, Victoria, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH